Navigation Links
Study evaluates costs and benefits of new chemotherapy drugs
Date:3/16/2010

ATLANTA New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost.

David H. Howard, PhD, and colleagues at Emory University's Rollins School of Public Health (RSPH), used a cancer registry database to measure trends in life expectancy and lifetime medical costs in 4,665 patients age 66 and older diagnosed with metastatic colon cancer between 1995 and 2005. Patients were classified according to whether they received one or more of the six chemotherapeutic agents approved for the treatment of metastatic colon cancer between 1996 and 2004.

Among those who received the new agents, life expectancy increased by 6.8 months and lifetime costs increased by $37,100, equating to a cost of $66,200 per year of life gained. After additional adjustments, the cost for each quality-adjusted life year (a year of life in perfect health) gained was $99,100, says lead study author Howard, associate professor of health policy and management, RSPH.

"New chemotherapeutic agents for colorectal cancer have been singled out as examples of high-cost/low-value medical care; no doubt they are the types of therapies that would receive close scrutiny if Medicare and other payers were to consider cost-effectiveness in coverage decisions," Howard and co-authors write.

"Our estimate of the cost per quality-adjusted life year gained, $100,000, is below most estimates of the willingness to pay for a life-year," the authors say. "However, continuation of Medicare's open-ended coverage policy for new chemotherapeutic agents and other expensive technologies will prove difficult to sustain as costs for the program continue to rise."

The study, "The Value of New Chemotherapeutic Agents for Metastatic Colorectal Cancer," is published in the March 16, 2010 issue of the Archives of Internal Medicine, a publication of the American Medical Association.


'/>"/>

Contact: Ashante Dobbs
adobbs2@emory.edu
404-727-5692
Emory University
Source:Eurekalert

Page: 1

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Pittsburgh, PA (PRWEB) November 28, 2014 An ... individuals have day to day. "I got this idea while ... walk to the bathroom," he said. , The Bed Buddy ... person to go to the bathroom. It eliminates the need ... well as promotes comfort and dignity. Easy to use and ...
(Date:11/28/2014)... 2014 ARTAS robotic hair transplant surgical ... time. PAI Medical Group hair transplant surgeons Chris Pawlinga, ... robotic hair transplant procedure in the Brentwood office on ... first in Tennessee and one of only three medical ... ARTAS robotic hair transplantation. Patients benefit from this minimally ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Based in ... organization focused on delivering exemplary solutions to the income ... ancillary benefits. In an effort to extend its reach ... and asset protection, Secura Consultants has brought aboard financial ... , “I am a big believer in specialization. When ...
(Date:11/28/2014)... TheBeautyPlace.com does it ... offering savings in abundance this retail season. , ... and cosmetic products such as SkinMedica, Neocutis, Glo ... competitive discounts on already reduced prices. At TheBeautyPlace.com ... giving customers savings year round. , TheBeautyPlace.com's Black ...
(Date:11/27/2014)... Albany, NY (PRWEB) November 28, 2014 ... industry is implant dentistry. The market for implant ... as supporting tools/instruments. The global market for dental ... and dental equipments. The dental equipment segment is ... with table of contents at: http://www.researchmoz.us/global-dental-market-report-2014-edition-report.html ...
Breaking Medicine News(10 mins):Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Matt Lee, CLU, ChFC Joins Secura Consultants as New Brokerage Consultant 2Health News:TheBeautyPlace.com Announces Double Savings 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 3
... A device consisting of a giant rubber tube may hold ... sea waves. , Invented in the UK, the ,Anaconda, is ... it would be cheap to manufacture and maintain, enabling it ... of wave energy converter. Cost has been a key barrier ...
... BEACH, Va., July 3 AMERIGROUP,Corporation (NYSE: AGP ... renewed its contract with the State of Tennessee,through June ... for the period April 1, 2008,through June 30, 2008, ... July 1,2008 through June 30, 2009. Expenditures on home ...
... July 3 Mylan Inc. (NYSE: MYL ... has,received tentative approval from the U.S. Food and ... (ANDA) for Linezolid,Tablets, 600 mg., Linezolid Tablets, ... Upjohn,s Zyvox(R) Tablets, which had U.S. sales of ...
... Rigel Pharmaceuticals,Inc. (Nasdaq: RIGL ) today announced that ... will present a company overview,at the Fourth Annual Collins ... a.m. EDT at The Mandarin Oriental Hotel in New ... or the subsequent archived recording,log on to http://www.rigel.com ...
... AND DUSK, DRAIN, SACRAMENTO, Calif., July 2 ... families and friends gathering outdoors, the,Mosquito and Vector ... take precautions against West Nile virus., "Individuals ... to prevent the spread of West Nile Virus ...
... long-term studies to assure medications don,t raise cardiovascular risks, ... to control type 2 diabetes should be subjected to ... the risk of heart problems, U.S. Food and Drug ... experts voted 14-to-2, at the end of a two-day ...
Cached Medicine News:Health News:Rubber 'snake' could help wave power get a bite of the energy market 2Health News:AMERIGROUP Renews Contract with Tennessee 2Health News:Remember West Nile Virus Safety This Fourth of July 2Health News:FDA Panel Calls for More Testing of Diabetes Drugs 2Health News:FDA Panel Calls for More Testing of Diabetes Drugs 3
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
(Date:11/26/2014)... 2014 Investor-Edge has initiated coverage on ... Horizon Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. ... JNJ ), and Theravance Inc. (NASDAQ: THRX ... at: http://investor-edge.com/register . On Tuesday, November 25, ... Dow Jones Industrial Average edged 0.02% lower, to finish the ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... bioMerieux, a world leader in the field of in ... that most critical care nurses are unaware of a simple ... The survey, conducted at the 2010 American Association of Critical ... of nurses expressed the need for new tools to battle ...
... 21, 2010 INVO Bioscience, Inc. (OTC Bulletin Board: ... on treatment options for patients diagnosed with infertility, today ... Bolivia.  The initial order of INVOcell devices was purchased ... Under the direction of clinic director Dr. Joaquin Lopez ...
Cached Medicine Technology:Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis 2Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis 3INVO Bioscience Announces First Shipments of INVOcell Into Bolivia 2INVO Bioscience Announces First Shipments of INVOcell Into Bolivia 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: